1196PPhase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated resultsE Borazanci, A Schram,I Brana,M Vieito Villar,E Garralda,A Spreafico,M Oliva,N Lakhani, R Wasserman, K Hoffman, R Hallett, J Anido,P Giblin,N Pandya,A Kelly,J Seoane,D D Von Hoff,L L Siu, D M Hyman,J TaberneroANNALS OF ONCOLOGY(2019)引用 2|浏览41暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要